The University Colorado Technology Transfer Office and Snell & Wilmer brought us a wonderful lunch seminar yesterday titled Patenting Early Stage Therapeutics. I took my first stab at capturing the audio and publishing the podcast here at CLSDF. The first few minutes are a bit choppy but the audio improves around the four minute mark.
Sit back and enjoy the talks by:
- Doug Graham, MD, PhD (CSO Caveo Therapeutics)
- Rick Duke, PhD (President & CEO ApopLogic Pharam, co-founder GlobeImmune)
- Tom Dougherty, JD (Snell & Wilmer)
Please let me know if you have any problems listening to the audio. thank you.